MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 64 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,500,125 | -2.3% | 7,364,438 | 0.0% | 0.51% | -1.3% |
| Q2 2023 | $9,721,058 | +86.7% | 7,364,438 | 0.0% | 0.52% | +136.4% |
| Q1 2023 | $5,205,921 | -5.7% | 7,364,438 | 0.0% | 0.22% | -5.2% |
| Q4 2022 | $5,523,329 | -12.9% | 7,364,438 | 0.0% | 0.23% | -11.8% |
| Q3 2022 | $6,342,000 | -38.1% | 7,364,438 | -19.4% | 0.26% | -32.4% |
| Q2 2022 | $10,239,000 | 0.0% | 9,142,067 | 0.0% | 0.39% | +24.3% |
| Q1 2022 | $10,239,000 | -30.0% | 9,142,067 | 0.0% | 0.31% | +10.6% |
| Q4 2021 | $14,627,000 | -33.9% | 9,142,067 | 0.0% | 0.28% | -24.1% |
| Q3 2021 | $22,124,000 | -19.3% | 9,142,067 | +5.7% | 0.37% | -9.0% |
| Q2 2021 | $27,418,000 | +27.8% | 8,649,300 | +35.9% | 0.41% | +29.3% |
| Q1 2021 | $21,452,000 | +118.0% | 6,365,500 | +131.6% | 0.32% | +124.8% |
| Q4 2020 | $9,841,000 | – | 2,748,999 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,220,938 | $16,299,000 | 0.94% |
| Boxer Capital, LLC | 4,029,649 | $10,558,000 | 0.36% |
| DAFNA Capital Management LLC | 199,425 | $522,000 | 0.17% |
| J. Goldman & Co LP | 443,517 | $1,162,000 | 0.08% |
| Ikarian Capital, LLC | 1,196,308 | $688,000 | 0.05% |
| HHLR ADVISORS, LTD. | 1,598,185 | $4,187,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 133,634 | $350,000 | 0.02% |
| F3Logic, LLC | 255 | $668,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 343,195 | $899,000 | 0.02% |
| CSS LLC/IL | 54,773 | $144,000 | 0.01% |